Patient Information Resources from ASCO What to Know ASCO’s Guideline on Preventing Vomiting Caused by Cancer Treatment

First Page		Document Content
Date: 2014-07-30 14:54:10 Organic chemistry 5-HT3 antagonist Dolasetron Ondansetron Chemotherapy Granisetron Management of cancer Vomiting Aprepitant Medicine Chemistry Antiemetics		Patient Information Resources from ASCO What to Know ASCO’s Guideline on Preventing Vomiting Caused by Cancer Treatment Add to Reading List Source URL: www.cancer.net Download Document from Source Website File Size: 258,85 KB Share Document on Facebook

	P11444 - ASCO2014 MEC and HEC DocID: 1a4Ek - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 19OCx - View Document
	Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella DocID: 19AF1 - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 199Dl - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 1987o - View Document